Overall rank by patents
#45,421
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, active 2017–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION).
The verdict
C360 holds 5 US patents across 5 technology areas, rank #45,421 of 50,000 tracked assignees.
C360 Technologies, Inc. has been granted 5 US utility patents between 2017 and 2022, placing C360 Technologies, Inc. at rank #45,421 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION). As a US Corporation, C360 Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, C360 sits between C.p. Medical Corporation (5 patents, rank #45,417) and Cable Detection Limited (5 patents, rank #45,425) - the closest US assignees by grant volume. The composite Innovation Score of 27.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 2 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. C360 Technologies, Inc.'s 17.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark C360 Technologies, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
C.P. Medical Corporation
5 patents
C2A-SEC, LTD
5 patents
C2N Diagnostics
5 patents
C3 Jian, LLC
5 patents
C4 Carbides Limited
5 patents
C7 SUGAR GMBH
5 patents
CA-DIGITAL GMBH
5 patents
CABLE DETECTION LIMITED
5 patents
C360 Technologies, Inc.
5 patents
What this shows C360 holds 5 patents at rank #45,421, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #45,421 in granted patent volume.
Other assignees with the most granted patents in C360's primary technology class.
C360's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 75% higher than 25% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 20.0% |
| 2018 | 1 | 20.0% |
| 2020 | 2 | 40.0% |
| 2022 | 1 | 20.0% |
Top 5 of 5 technology areas
Overall rank by patents
#45,421
Across all tracked assignees
27.8 out of 100
How to use this portfolio
C360's 5 grants land it in the top 75% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.